Clin2
NCT07747324Likely a fitRecruiting

Testing ayahuasca for psychogenic non-epileptic seizures

Non Epileptic Seizures

Treatments studied

Part of Brain & nervous system clinical trials.

This trial tests whether a single dose of ayahuasca, a plant-based brew, can reduce psychogenic non-epileptic seizures (PNES). It may help if you are willing to stop psychiatric medications temporarily and have no other serious mental health conditions.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
15 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 60 years old.
  • You have been diagnosed with psychogenic non-epileptic seizures (PNES) and do not have epilepsy.
  • You are willing to gradually stop taking psychiatric medications (like antidepressants or anti-anxiety drugs) before the trial.
  • You have not used ayahuasca before.
  • You do not have a history of substance use disorder.
  • You are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07317232Recruiting
Ayahuasca and Esketamine for Premenstrual Symptoms

This trial is testing whether a plant-based medicine called ayahuasca and a nasal spray (esketamine) can help with premenstrual symptoms. It's only for healthy people without any medical conditions.

Ribeirão Preto
NCT07317206Recruiting· Phase 2
Ayahuasca vs Esketamine for PTSD

This trial tests two treatments—ayahuasca and esketamine—to see if they can help people with PTSD. It's for people who have PTSD and no other health problems.

Ribeirão Preto, São Paulo
NCT07317219Recruiting
Ayahuasca and esketamine on body image

This study tests how ayahuasca and esketamine affect how you see your body. Healthy volunteers are needed to help learn more.

Ribeirão Preto, São Paulo
NCT06769659Recruiting· Phase 2
Testing NPT 2042 for absence seizures in genetic epilepsy

This trial tests a new medication called NPT 2042 for people with a type of epilepsy that causes brief staring spells (absence seizures). It aims to see if the drug can reduce seizure frequency compared to a placebo (an inactive pill).

Little Rock, Arkansas
NCT06570954Recruiting
Trial of retraining and control therapy for non-epileptic seizures

This study tests a therapy called ReACT for adults who have psychogenic non-epileptic seizures (PNES). The goal is to help reduce these seizures and improve quality of life.

Birmingham, Alabama
NCT05096273Recruiting
Training for control and expectations in PNES therapy

This study tests a treatment approach that aims to improve a sense of control and change symptom expectations for children or teens with psychogenic non-epileptic seizures (PNES). It also involves family support so the treatment fits your home life and goals.

Birmingham, Alabama

Hear when a new Non Epileptic Seizures trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.